{
    "organizations": [],
    "uuid": "39acda39d88b737708c50339598ca428d0a373a4",
    "author": "Rory Jones",
    "url": "https://www.wsj.com/articles/teva-pharmaceutical-shares-plunge-after-quarterly-loss-and-2018-outlook-warning-1518116066",
    "ord_in_thread": 0,
    "title": "Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Israel’s Teva Pharmaceutical Industries Ltd. on Thursday said it took a $17 billion charge against the value of its U.S. generics business and posted a $11.6 billion fourth-quarter loss, capping a tumultuous 2017 that saw a management and boardroom shake-up.\nWhile the world’s biggest generic drugmaker has struggled for months, the magnitude of the loss and a warning from Chief Executive Kare Schultz that 2018 could prove just as difficult sent the firm’s shares reeling.\n... ",
    "published": "2018-02-08T21:54:00.000+02:00",
    "crawled": "2018-02-08T22:51:27.034+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "israel",
        "teva",
        "pharmaceutical",
        "industry",
        "thursday",
        "said",
        "took",
        "billion",
        "charge",
        "value",
        "generic",
        "business",
        "posted",
        "billion",
        "loss",
        "capping",
        "tumultuous",
        "saw",
        "management",
        "boardroom",
        "world",
        "biggest",
        "generic",
        "drugmaker",
        "struggled",
        "month",
        "magnitude",
        "loss",
        "warning",
        "chief",
        "executive",
        "kare",
        "schultz",
        "could",
        "prove",
        "difficult",
        "sent",
        "firm",
        "share",
        "reeling"
    ]
}